These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 629247)

  • 21. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].
    Sultan Y; Brouet JC
    Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired factor VIII inhibitor in a non-haemophilic boy.
    Klukowska A; Łaguna P; Obitko-Płudowska A; Niedzielska K; Malinowska I; Rokicka-Milewska R
    Haemophilia; 2003 Sep; 9(5):642-5. PubMed ID: 14511308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-inhibitor Coagulant Complex (Autoplex) for treatment of factor VIII inhibitors in hemophilia.
    Abildgaard CF; Penner JA; Watson-Williams EJ
    Blood; 1980 Dec; 56(6):978-84. PubMed ID: 6777002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitor treatment using unactivated prothrombin complex concentrates: the Pennsylvania experience--1978-1982.
    Eyster ME; Spero JA; Catalano PM; Gill FM; Lusch CJ; Kajani MK; Barron LE; DeGreen HP; Shapiro SS; Lewis JH
    Prog Clin Biol Res; 1984; 150():309-22. PubMed ID: 6431435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors.
    Hilgartner MW; Knatterud GL
    Blood; 1983 Jan; 61(1):36-40. PubMed ID: 6401216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter: Concentrates of clotting-factor IX.
    Mannucci PM; Bader R; Ruggeri ZM
    Lancet; 1976 Jan; 1(7949):41. PubMed ID: 54544
    [No Abstract]   [Full Text] [Related]  

  • 29. Activated prothrombin concentrate for patients with factor VIII inhibitors.
    Kurczynski EM; Penner JA
    N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of non-activated prothrombin concentrate in the management of haemophilia A with factor VIII antibodies.
    Price DA; d'Souza S; Ekert H
    Aust N Z J Med; 1977 Jun; 7(3):286-90. PubMed ID: 269689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of bleeds in hemophilia patients with inhibitors: emerging data and clinical direction.
    Leissinger CA
    Am J Hematol; 2004 Oct; 77(2):187-93. PubMed ID: 15389908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired circulating anticoagulant in classical hemophilia: treatment with prothrombin concentrate.
    Rosen R; Mikel T; Corrigan JJ
    Ariz Med; 1977 May; 34(5):340-2. PubMed ID: 883905
    [No Abstract]   [Full Text] [Related]  

  • 33. [Emergency treatment of haemophilia A with factor VIII inhibitors using activated prothrombin complex concentrates (author's transl)].
    Rasche H; Bindewald H; Köhle W; Scheck R; Heinrich R; Seibert K
    Dtsch Med Wochenschr; 1977 Mar; 102(9):319-23. PubMed ID: 300053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of the treatment of children with factor VIII inhibitors with prothrombin-complex concentrates.
    Ekert H; Smibert E; Exton J
    Med J Aust; 1987 Sep; 147(5):230-3. PubMed ID: 3118153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of inhibitors in patients with severe and moderate hemophilia A treated with factor VIII concentrates.
    Schwarzinger I; Pabinger I; Korninger C; Haschke F; Kundi M; Niessner H; Lechner K
    Am J Hematol; 1987 Mar; 24(3):241-5. PubMed ID: 3103425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine.
    Ambriz Fernandez R; Quintana Gonzalez S; Martinez Murillo C; Dominguez Garcia V; Rodriguez Moyado H; Collazo Jaloma J
    Arch Med Res; 1996; 27(1):15-8. PubMed ID: 8867361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of factor VIII: detection and treatment.
    Brettler DB
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():21-5. PubMed ID: 7886576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates.
    de Biasi R; Rocino A; Papa ML; Salerno E; Mastrullo L; De Blasi D
    Thromb Haemost; 1994 May; 71(5):544-7. PubMed ID: 8091377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment with prothrombin complex concentrate of postoperative bleeding in a haemophiliac with a factor VIII inhibitor.
    Lowe GD; Harvie A; Forbes CD; Prentice CR
    Br Med J; 1976 Nov; 2(6044):1110-1. PubMed ID: 990791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.